Rigetti stock (NASDAQ: RGTI) has produced one of the market’s most dramatic runs, up roughly 5,000% over the past year, and a growing number of Wall Street analysts are arguing the stock’s momentum can continue, even after the spectacular gains. Their bullish case rests on accelerating commercial traction, fresh government work, and what they say

Shares of WW International rose nearly 6% in premarket trading on Monday after the company announced a new partnership with Amazon to deliver GLP-1 weight-loss drugs and other prescription medications directly to its members. The move is part of WeightWatchers’ broader effort to expand access to obesity treatments and strengthen its digital health offering following

The S&P 500 Index and its top ETFs, like VOO, IVV, and SPY were highly volatile last week as investors reacted to the trade issues between the US and China, and credit quality concerns in the regional banking industry. This article explores some of the top news that will move these assets this week. US

Shares of Cleveland-Cliffs rose nearly 19% in premarket trading on Monday after the company reported strong demand for its US-produced steel and revealed plans to explore opportunities in rare-earth mineral production. The steelmaker credited the Trump administration’s trade policy, including a 50% tariff on imported steel, for stimulating domestic demand and supporting its business expansion.

Rare earth stocks continue to draw strong investor attention, and Wall Street remains optimistic about the sector’s long-term prospects. On Monday, William Blair analyst Neal Dingmann initiated coverage of USA Rare Earth (USAR) with an outperform rating, citing expectations that the US government will continue investing in domestic rare earth producers. Shares of USA Rare

Wall Street opened higher on Monday as investors’ sentiment seems upbeat about the upcoming slew of earnings and the possibility of another rate cut by the Federal Reserve. The Dow Jones Industrial Average gained 194 points, or 0.4%, while the S&P 500 rose 0.6% and the Nasdaq Composite added 0.8%. An optimistic signal from the

Biotech stocks are lighting up the tape today, with several clinical-stage companies posting double-digit gains on fresh catalysts. From earnings beats to promising trial data and billion-dollar partnerships, investors are rewarding progress across oncology, immunology, and drug delivery platforms. Here’s a quick look at four making the biggest move on Monday: CorMedix, RAPT Therapeutics, Celcuity,

Japanese stocks surged to fresh highs on Monday, with the Nikkei 225 jumping 3.37% to close at 49,185.5 and the broader Topix gaining 2.46% to end at 3,248.45. The rally came after reports that the Liberal Democratic Party and the Japan Restoration Party reached a coalition agreement, potentially ushering in a more stable and reform-oriented

Tesla stock (NASDAQ: TSLA) advanced on Monday, as investors positioned themselves ahead of the electric vehicle maker’s third-quarter earnings report scheduled for Wednesday, October 22. The stock rose approximately over 2% to $448.32 in early trading, continuing a robust rally that has seen shares climb over 30% in the past three months and roughly 80%

Apple shares rose to record levels on Monday following a Loop Capital upgrade to buy from hold, marking the latest signal of optimism around the tech giant’s iPhone sales. Shares rose 3.1% to an all time high on Monday, beating the previous high reached in December 2024. Despite this uptick, Apple remains up just 6%